Health Day: Bivalent COVID Boosters Offer No Extra Protection, Studies Suggest.
Key Takeaways:
Two new studies show that the updated COVID boosters from Pfizer and Moderna are no better at guarding against infection than the original shots are[.]
"Imprinting" may be at play, where the body already recognizes the virus so it doesn't react to a newer vaccine[.]
But experts [Ah..."Teh Experts!" - DD] are divided on the continuing value of boosters, and some say ["some say." How reassuring! - DD] older, high-risk folks can still see benefits from the newer booster[.]
[.]
The new mRNA bivalent boosters produced by Moderna and Pfizer only attack the COVID-19 virus about as well as the companies' first-wave vaccines, according to a blood testing study led by renowned virologist Dr. David Ho, a professor of microbiology and immunology at Columbia University, in New York City.
The bivalent shots also failed to promote higher antibody levels or a better immune response than the original COVID-19 vaccines, according to another study led by Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, in Boston. Both studies were published online Jan. 11 in the New England Journal of Medicine.
Oh, Drake, that's "Health Day" - what do they know?
Well, here are the links to the studies:
New England Journal of Medicine: Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.
New England Journal of Medicine: Bivalent Covid-19 Vaccines — A Cautionary Tale.
Dan H. Barouch, M.D., Ph.D. Credentials.
Gregory A. Poland, M.D. Credentials.
David D. Ho, M.D. Credentials.
The Epoch Times: FDA Adviser Says Young and Healthy People Shouldn’t Get Latest COVID Boosters.
“I believe we should stop trying to prevent all symptomatic infections in healthy, young people by boosting them with vaccines containing mRNA from strains that might disappear a few months later,” wrote Dr. Paul A. Offit, an FDA vaccine panel adviser and professor of pediatrics at the Children’s Hospital of Philadelphia, in New England Journal of Medicine on Jan. 11.
In his article, Offit cited two studies suggesting that bivalent boosters, which target the original COVID-19 strain and two Omicron subvariants BA.4 and BA. 5, do not “elicit superior immune responses.”
[.]
An FDA spokesperson Abigail Capobianco responded to Offit’s article this week, telling NBC News that Offit allegedly used “selective” data to reach his conclusions and that “we strongly believe that the totality of the available evidence continues to support the use of these vaccines in all age groups.”
“Dr. Offit is entitled to his opinion about the effectiveness of the COVID-19 bivalent vaccines used as boosters,” Capobianco also said.
[.]
“I was angry to find out that there was data that was relevant to our decision that we didn’t get to see,” Offit told CNN. “Decisions that are made for the public have to be made based on all available information—not just some information, but all information.”
Abigail Capobianco is a Press Officer for the FDA. Her degrees in Medicine or Science? None.
According to Capobianco's LinkedIN, she has a Master of Arts (M.A.) in Health Communication from Emerson College and a BA in Journalism from Northeastern College. In other words, she's just an FDA Spin Doctor.
There's nothing wrong with the degrees she has, but she's not a Medical Doctor. She has no business or the credentials to be giving or providing medical advice on any level.
 | ||
| Looks ghoulish. I wouldn't trust her on any issue. | |
In related news:
Nexus News: Unvaccinated blood is in very high demand. Here's the PDF.
Dr. Panda, Substack: Demand for unvaccinated blood soaring.
Twitter: Dr. Panda.
No comments:
Post a Comment